Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

BACKGROUND: The incidence of coronavirus disease 2019 (Covid-19) among adolescents between 12 and 17 years of age was approximately 900 per 100,000 population from April 1 through June 11, 2021. The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in adolescents are unknown. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Kashif, Berman, Gary, Zhou, Honghong, Deng, Weiping, Faughnan, Veronica, Coronado-Voges, Maria, Ding, Baoyu, Dooley, Jacqueline, Girard, Bethany, Hillebrand, William, Pajon, Rolando, Miller, Jacqueline M., Leav, Brett, McPhee, Roderick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385554/
https://www.ncbi.nlm.nih.gov/pubmed/34379915
http://dx.doi.org/10.1056/NEJMoa2109522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385554/
https://www.ncbi.nlm.nih.gov/pubmed/34379915
http://dx.doi.org/10.1056/NEJMoa2109522

Ejemplares similares